Table 4.
Multivariate logistic regression analysis regarding the use of different therapeutic regimens in COVID-19 transplant patients and its association with mortality and need for mechanical ventilation (data are presented as odds ratio with 95% confidence interval)
| Drug | Survival | Mechanical ventilation | ||
|---|---|---|---|---|
| OR (95% CI) | P value | OR (95% CI) | P value | |
| Interferon | 0.14 (0.02–1.94) | 0.11 | 2.05 (0.33–12.66) | 0.44 |
| Hydroxychloroquine | 0.87 (0.90–1.34) | 0.49 | 1.19 (0.70–2.39) | 0.20 |
| Lopinavir/Ritonavir | 0.14 (0.02–0.87) | 0.04 | 3.22 (0.64–16.27) | 0.16 |
| Remdesivir | 2.20 (0.07–0.81) | 0.02 | 1.70 (0.85–4.40) | 0.11 |
| Corticosteroid (Dexamethasone and High dose methylprednisolone | 0.33 (0.03–3.42) | 0.35 | 4.59 (0.48–43.72) | 0.19 |
| Tocilizumab | 1.10(0.05–0.92) | < 0.001 | 1.91 (0.07–1.10) | 0.09 |
OR odds ratio; CI confidence interval